Ignite Creation Date:
2024-05-05 @ 5:24 PM
Last Modification Date:
2024-10-26 @ 9:31 AM
Study NCT ID:
NCT00445744
Status:
COMPLETED
Last Update Posted:
2018-01-02
First Post:
2007-03-07
Brief Title:
Cyclophosphamide and Busulfan Followed by Donor Stem Cell Transplant in Treating Patients With Myelofibrosis Acute Myeloid Leukemia or Myelodysplastic Syndrome
Sponsor:
Fred Hutchinson Cancer Center
Organization:
Fred Hutchinson Cancer Center
Conditions & Keywords Data
Conditions:
| Name |
|---|
| Untreated Childhood Acute Myeloid Leukemia and Other Myeloid Malignancies |
| Adult Acute Myeloid Leukemia in Remission |
| Adult Acute Myeloid Leukemia With 11q23 MLL Abnormalities |
| Adult Acute Myeloid Leukemia With Del5q |
| Adult Acute Myeloid Leukemia With Inv16p13q22 |
| Adult Acute Myeloid Leukemia With t1517q22q12 |
| Adult Acute Myeloid Leukemia With t1616p13q22 |
| Adult Acute Myeloid Leukemia With t821q22q22 |
| Childhood Acute Myeloid Leukemia in Remission |
| Childhood Myelodysplastic Syndromes |
| de Novo Myelodysplastic Syndromes |
| Essential Thrombocythemia |
| Myelodysplastic Syndrome With Isolated Del5q |
| Polycythemia Vera |
| Previously Treated Myelodysplastic Syndromes |
| Primary Myelofibrosis |
| Recurrent Adult Acute Myeloid Leukemia |
| Recurrent Childhood Acute Myeloid Leukemia |
| Secondary Acute Myeloid Leukemia |
| Secondary Myelodysplastic Syndromes |
| Secondary Myelofibrosis |
| Untreated Adult Acute Myeloid Leukemia |
Keywords: